DaVita Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
03-04

DJ DaVita Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of DaVita Inc. $(DVA)$ slipped 3.23% to $143.10 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.76% to 5,849.72 and Dow Jones Industrial Average falling 1.48% to 43,191.24.

The stock's fall snapped a four-day winning streak.

DaVita Inc. closed 20.32% below its 52-week high of $179.60, which the company reached on January 31st.

The stock underperformed when compared to some of its competitors Monday, as UnitedHealth Group Inc. $(UNH)$ fell 1.67% to $467.05, Icon PLC $(ICLR)$ fell 2.74% to $184.81, and Quest Diagnostics Inc. $(DGX)$ rose 2.34% to $176.95.

Trading volume (1.3 M) eclipsed its 50-day average volume of 859,013.

Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

March 03, 2025 17:17 ET (22:17 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10